CV Lattes
ORCID
Abstract
Oral squamous cell carcinoma (SCC) is the most common oral cancer in the world and an estimated 370,000 new cases per year. Survival rates remain low, below 50% after 5 years of diagnosis and with up to 78% rates of recurrence. Thus, new potential therapeutic targets are urgently needed to be discovered to assist in therapeutic strategies. Recently, our group has unprecedentedly validated…